Q2 2025 Holdings
Filed 2025-08-11 | 73 holdings | $309.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $4.2M | 814,416 | 1.3% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $4.3M | 330,600 | 1.4% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $4.5M | 335,944 | 1.5% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $4.8M | 3,443,659 | 1.5% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $4.9M | 7,407,906 | 1.6% |
| Tempus AI Inc(TEM) | CL A | 88023B103 | $5.1M | 80,167 | 1.6% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $5.3M | 562,594 | 1.7% |
| Ikena Oncology Inc | COM | 45175G108 | $5.5M | 4,091,118 | 1.8% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $6.5M | 122,260 | 2.1% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $6.7M | 2,591,525 | 2.2% |
| Civeo Corp CDA(CVEO) | COM NEW | 17878Y207 | $7.3M | 317,411 | 2.4% |
| Holley Inc(HLLY) | COM | 43538H103 | $8.2M | 4,112,361 | 2.7% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $9.3M | 255,238 | 3.0% |
| Sagimet Biosciences Inc(SGMT) | COM SER A | 786700104 | $10.1M | 1,328,351 | 3.3% |
| Conduent Inc(CNDT) | COM | 206787103 | $11.8M | 4,456,848 | 3.8% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $13.6M | 3,728,106 | 4.4% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $14.2M | 4,928,040 | 4.6% |
| Tourmaline BIO Inc(TRML) | COM | 89157D105 | $15.9M | 997,107 | 5.1% |
| Evercommerce Inc(EVCM) | COM | 29977X105 | $17.2M | 1,641,929 | 5.6% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $18.0M | 2,385,972 | 5.8% |
| Blue OWL Capital Corporation(OBDC) | COM | 69121K104 | $29.3M | 2,045,070 | 9.5% |
| Nuveen Churchill Direct Lend(NCDL) | COM SHS | 67090S108 | $65.4M | 4,039,553 | 21.1% |